首页> 美国卫生研究院文献>BMC Clinical Pharmacology >High content imaging quantification of multiple in vitro human neurogenesis events after neurotoxin exposure
【2h】

High content imaging quantification of multiple in vitro human neurogenesis events after neurotoxin exposure

机译:高含量成像量化神经毒素暴露后多个体外人类神经发生事件

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundOur objective was to test neural active compounds in a human developmental neurotoxicity (DNT) model that represents neural tube stages of vulnerability. Previously we showed that 14 days in vitro (DIV 14) was sufficient to generate cryopreserved neuronal cells for post thaw neurite recovery assays. However, short exposure and assessment may not detect toxicants that affect an early neurogenesis continuum, from a mitotic human neural progenitor (hNP) cell population through the course of neurite outgrowth in differentiating neurons. Therefore, we continuously exposed differentiating hNP cells from DIV 0 through DIV 14 to known toxicants and endocrine active compounds in order to assess at DIV 14 effects of these compounds in a human DNT maturation model for neurogenesis.
机译:背景我们的目的是在代表发育脆弱性的神经管阶段的人类发育神经毒性(DNT)模型中测试神经活性化合物。以前我们证明体外14天(DIV 14)足以产生冻存的神经元细胞,用于解冻后的神经突恢复测定。但是,短暂的暴露和评估可能无法检测到影响有早期神经生成连续体的有毒物质,这些有毒物质是从有丝分裂的人类神经祖细胞(hNP)到分化神经元中神经突生长的过程而产生的。因此,我们不断将分化的hNP细胞从DIV 0到DIV 14暴露于已知的有毒物质和内分泌活性化合物,以评估这些化合物在人DNT神经生成成熟模型中在DIV 14的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号